Alabama Medicaid
Ingenix to Conduct Medicaid Provider Post Payment Reviews
The Alabama Medicaid Agency recently awarded a two-year contract to Ingenix Public Sector Solutions, Inc. to conduct federally mandated provider post payment reviews and recover any identified inappropriate payments made to providers. Post payment reviews will be conducted for all provider groups such as physicians, pharmacies, durable medical equipment, home health, dental, hospitals, etc. Ingenix will be reviewing claims filed for the past two years.
Updated information from the Alabama Medicaid Agency
Medicaid Matters, the Alabama Medicaid Agency’s online newsletter - February issue
In this issue:
• State awarded $10.5 million to build electronic health record system
• Enhanced FMAP extension needed to prevent drastic Medicaid cuts
• Dentists, Medicaid explore ideas to improve state dental program
• Telemedicine brings specialty care to medically underserved
(posted 2/26/10) (read more)
Medicaid HP ALERT letter - Cost Saving Measures
(posted 1/26/10) (read more) (provider alerts)
(back to top)
FDA News
PRODUCT INFORMATION:
FDA Approves Name Change for Heartburn Drug Kapidex
(posted 3/4/10) (read more)
FDA Approves First Generic Tamsulosin to Treat Enlarged Prostate Gland
(posted 3/3/10) (read more)
Baxter HomeChoice and HomeChoice PRO Automated Peritoneal Dialysis Systems: Class I Recall
(posted 3/3/10) (read more)
FDA Approves Therapy to Treat Gaucher Disease
(posted 2/26/10) (read more)
StatSpin Express 4 Centrifuges Model 510: Class 1 Recall
(posted 2/26/10) (read more)
FDA Approves Pneumococcal Disease Vaccine with Broader Protection
(posted 2/24/10) (read more)
FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms
(posted 2/23/10) (read more)
FDA Announces Possible Safety Concern for HIV Drug Combination
(posted 2/23/10) (read more)
FDA Drug Safety Communication: Ongoing review of Avandia (rosiglitazone) and cardiovascular safety
(posted 2/22/10) (read more)
PRODUCT APPROVAL:
FDA Grants Tentative Approval for Nevirapine Tablets for Oral Suspension, 50 mg
(posted 2/24/10) (read more)
FDA Approves Pneumococcal Disease Vaccine with Broader Protection
(posted 2/24/10) (read more)
(back to top)
Weekly FDA Generic Drug Approval Updates
March 5, 2010
• Adalat (nifedipine) Extended-Release Tablets, Bayer HealthCare, Labeling Revision
• Avelox (moxifloxacin hydrochloride) Tablets, Bayer HealthCare Pharmaceuticals, Inc., Labeling Revision
• Avelox in Sodium Chloride 0.8% in Plastic Container (moxifloxacin hydrochloride) I.V. Injection, Bayer HealthCare Pharmaceuticals, Inc., Labeling Revision
• ChloraPrep One-Step Sepp (chlorhexidine gluconate and isopropyl alcohol) Topical Swab, CareFusion, LLC, Labeling Revision
• Femara (letrozole) Tablets, Novartis Pharmaceuticals Corporation, Efficacy Supplement with Clinical Data to Support
• Fluvastatin Capsules, Teva Pharmaceuticals, Tentative Approval
• Invega (paliperidone) Extended-Release Tablets, Johnson & Johnson Pharmaceutical, Labeling Revision
• Levetiracetam Oral Solution, Wockhardt, Approval
• Rapaflo (silodosin) Capsules, Watson Laboratories, Inc., Labeling Revision
• Xifaxan (rifaximin) Tablets, Salix Pharmaceuticals, Inc., Labeling Revision
• Zocor (simvastatin) Tablets, Merck & Co., Inc., Labeling Revision
March 3, 2010
• Exalgo (hydromorphone HCl) Extended-Release Tablets, ALZA Corporation, Approval
• Fosamax (alendronate sodium) Tablets, Merck & Co., Inc., Labeling Revision
• Fosamax (alendronate sodium) Oral Solution, Merck & Co., Inc., Labeling Revision
• Fosamax Plus D (alendronate sodium and cholecalciferol) Tablets, Merck & Co., Inc., Labeling Revision
• Norditropin (somatropin [rDNA origin]) Injection, Novo Nordisk Inc., Manufacturing Change or Addition
• Tamsulosin Hydrochloride Capsules, IMPAX Laboratories, Inc., Approval
• Temozolomide Capsules, Barr Laboratories, Inc., Approval
(back to top)
Need to Know
Food Poisoning Costs U.S. $152 Billion a Year
(posted 3/3/10) (read more)
CDC Releases First–Ever County–Level Report on Heart Disease Hospitalizations
(posted 3/1/10) (read more)
ACIP Provisional Recommendations for Vaccines
(read more)
Pharmacy Verification Network
Single-source, secure database of pharmacy managed profiles required for verification and credentialing (overview) (learn more)
Communication to Pharmacy Colleagues from Merck regarding FDA LABA Safety Decision
(posted 2/19/10) (read more)
Read more pharmacy news here...
(back to top)
|
